Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Reproductive Tract Infections D060737 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Pneumonia, Lipid D011017 2 associated lipids
Protozoan Infections D011528 6 associated lipids
Tick Bites D064927 1 associated lipids
Granulomatous Mastitis D058890 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Sharpton R et al. Do cystic fibrosis patients on azithromycin need electrocardiogram monitoring? 2017 Pulm Pharmacol Ther pmid:28219728
Yamada K et al. Azithromycin inhibits MUC5AC induction via multidrug-resistant Acinetobacter baumannii in human airway epithelial cells. 2014 Pulm Pharmacol Ther pmid:24910464
Morinaga Y et al. Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. 2009 Pulm Pharmacol Ther pmid:19716898
Kang JY et al. Long-term azithromycin ameliorates not only airway inflammation but also remodeling in a murine model of chronic asthma. 2016 Pulm Pharmacol Ther pmid:26778828
Aubert JD et al. Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteers. 1998 Pulm Pharmacol Ther pmid:10101742
Florescu DF et al. Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis. 2009 Pulm Pharmacol Ther pmid:19328860
Weinschenk K and Schwartz AC A case report of closed-eye visual hallucinations. 2011 Jan-Feb Psychosomatics pmid:21300201
Serwin AB et al. Gonorrhoea in 21st century--international and Polish situation. 2014 Przegl Epidemiol pmid:25004630
Biernat-Sudolska M et al. [Voice on the treatment of ureaplasmas infections]. 2009 Przegl Epidemiol pmid:19522233
Szpakowski M and Szawłowski A [Azithromycin (Sumamed) administration in empiric treatment of nosocomial pneumonia in upper digestive tract cancer patients]. 2003 Prz. Lek. pmid:14575010
Hanssens L et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. 2016 Prostaglandins Leukot. Essent. Fatty Acids pmid:27154364
Bakheit AH et al. Azithromycin. 2014 Profiles Drug Subst Excip Relat Methodol pmid:24794904
Bulkley D et al. Revisiting the structures of several antibiotics bound to the bacterial ribosome. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20876130
Davis AR et al. Sequence selectivity of macrolide-induced translational attenuation. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25313041
Retallack H et al. Zika virus cell tropism in the developing human brain and inhibition by azithromycin. 2016 Proc. Natl. Acad. Sci. U.S.A. pmid:27911847
Palmer NO Pharmaceutical prescribing for children. Part 3. Antibiotic prescribing for children with odontogenic infections. 2006 Prim Dent Care pmid:16393495
James GD et al. Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study. 2013 Prim Care Respir J pmid:23839240
de Barbeyrac B [Current aspects of Chlamydia trachomatis infection]. 2013 Presse Med pmid:23419460
Chanal J et al. [What's new in the diagnosis and treatment of Neisseria gonorrhoeae]. 2013 Presse Med pmid:23433914
Yaws, a non-venereal treponemal infection. Still endemic in some parts of the world. 2012 Prescrire Int pmid:23016260
Antibiotic therapy for trachoma. 2009 Prescrire Int pmid:19750586
Intrauterine devices: antibiotic prophylaxis not necessary during insertion. 2001 Prescrire Int pmid:11718174
Azithromycin: cardiovascular deaths. 2013 Prescrire Int pmid:23383407
Gramellini D et al. Mid-trimester amniocentesis and antibiotic prophylaxis. 2007 Prenat. Diagn. pmid:17607664
Giorlandino C et al. Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial. 2009 Prenat. Diagn. pmid:19294678
Miedinger D [Dysuria and urethral discharge after travel abroad]. 2006 Praxis (Bern 1994) pmid:16640179
Steurer J [In Process Citation]. 2013 Praxis (Bern 1994) pmid:23919943
Ryser C and Hasler P [[Reactive arthritis]. 2010 Praxis (Bern 1994) pmid:21049437
Pollock E and Hasse B [CME. Pertussis]]. 2015 Praxis (Bern 1994) pmid:26331198
Lanz J and Lautenschlager S [CME Dermatology 16/Answer: Fever, Pustules and Joint Pain as Vacation Mementoes]. 2018 Praxis (Bern 1994) pmid:29921188
Steurer J [Azithromycin in the treatment of pneumonia in the elderly is not dangerous]. 2014 Praxis (Bern 1994) pmid:25228579
Cramer CL et al. Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician. 2017 Postgrad Med pmid:28116959
Barlam TF Expedited treatment for partners of patients with gonorrhea and/or chlamydial infection: impact on rates of persistence or recurrence. 2005 Postgrad Med pmid:15948359
Rapp RP Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. 2002 Postgrad Med pmid:19667590
Eagan L Data on HIV infection in women expands. 1999 Posit Living pmid:11367336
Rifabutin for MAC questioned. 1995 Jul-Aug Posit Aware pmid:11362571
D'Amico R ICAAC update on opportunistic infections. 1996 Nov-Dec Posit Aware pmid:11363974
Faber M et al. [Evaluation of clinical effectiveness and direct costs of azithromycin treatment for exacerbation of chronic obstructive pulmonary disease in hospitalized patients and ambulatory care]. 2004 Pol. Merkur. Lekarski pmid:15524029
Breborowicz A [Azithromycin in the therapy of lower respiratory tract infection in children]. 2008 Pol. Merkur. Lekarski pmid:19177779
Breborowicz A [Antibiotic therapy in asthma exacerbation and in cystic fibrosis in children]. 2011 Pol. Merkur. Lekarski pmid:21675140
Faber M et al. [Comparative analysis of the effectiveness and costs of azithromycin and cefoperazone treatment of patients during COPD exacerbation]. 2003 Pol. Merkur. Lekarski pmid:12712826
Mammen MJ and Sethi S Macrolide therapy for the prevention of acute exacerbations in chronic obstructive pulmonary disease. 2012 Pol. Arch. Med. Wewn. pmid:22353707
Zygner W et al. Azithromycin in the treatment of a dog infected with Giardia intestinalis. 2008 Pol J Vet Sci pmid:18942546
Aktan B et al. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. 2003 Nov-Dec Pol J Pharmacol pmid:14730107
Handrick W et al. [Pulmonary infection due to Mycobacterium malmoense]. 2005 Pneumologie pmid:15944898
Köhler T et al. Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. 2010 PLoS Pathog. pmid:20463812
West SK et al. Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial. 2017 PLoS ONE pmid:28662043
Zhao X et al. Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids. 2016 PLoS ONE pmid:27907030
Yang D et al. The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings. 2018 PLoS ONE pmid:29377957
Banerjee B et al. Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin. 2012 PLoS ONE pmid:23284981